J.P. Marvel Investment Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $18.7M | Sell |
38,035
-85
| -0.2% | -$46.1K | 2.65% | 11 |
|
|
2025
Q4 | $22.1M | Hold |
38,120
| – | – | 3.07% | 10 |
|
|
2025
Q3 | $18.5M | Sell |
38,120
-61
| -0.2% | -$28.4K | 2.69% | 13 |
|
|
2025
Q2 | $15.5M | Sell |
38,181
-127
| -0.3% | -$53.1K | 2.49% | 12 |
|
|
2025
Q1 | $19.1M | Sell |
38,308
-171
| -0.4% | -$92.6K | 3.3% | 9 |
|
|
2024
Q4 | $20M | Sell |
38,479
-92
| -0.2% | -$50.6K | 3.3% | 8 |
|
|
2024
Q3 | $23.9M | Sell |
38,571
-89
| -0.2% | -$52.7K | 3.89% | 6 |
|
|
2024
Q2 | $21.4M | Sell |
38,660
-20
| -0.1% | -$11.5K | 3.51% | 7 |
|
|
2024
Q1 | $22.5M | Sell |
38,680
-248
| -0.6% | -$139K | 3.89% | 6 |
|
|
2023
Q4 | $20.7M | Sell |
38,928
-267
| -0.7% | -$129K | 4.09% | 5 |
|
|
2023
Q3 | $19.8M | Sell |
39,195
-18
| -0% | -$9.59K | 4.27% | 5 |
|
|
2023
Q2 | $20.5M | Sell |
39,213
-205
| -0.5% | -$111K | 4.27% | 5 |
|
|
2023
Q1 | $22.7M | Sell |
39,418
-151
| -0.4% | -$85.1K | 5.12% | 3 |
|
|
2022
Q4 | $21.8M | Sell |
39,569
-215
| -0.5% | -$114K | 5.11% | 2 |
|
|
2022
Q3 | $20.2M | Buy |
39,784
+1,723
| +5% | +$964K | 5.14% | 2 |
|
|
2022
Q2 | $20.7M | Sell |
38,061
-76
| -0.2% | -$41.8K | 4.97% | 3 |
|
|
2022
Q1 | $22.5M | Sell |
38,137
-259
| -0.7% | -$149K | 4.58% | 4 |
|
|
2021
Q4 | $25.6M | Sell |
38,396
-473
| -1% | -$295K | 5.01% | 4 |
|
|
2021
Q3 | $22.2M | Sell |
38,869
-78
| -0.2% | -$42.8K | 6.69% | 2 |
|
|
2021
Q2 | $19.6M | Sell |
38,947
-248
| -0.6% | -$117K | 4.18% | 4 |
|
|
2021
Q1 | $17.9M | Sell |
39,195
-25
| -0.1% | -$11.9K | 4.23% | 4 |
|
|
2020
Q4 | $18.3M | Sell |
39,220
-80
| -0.2% | -$37.5K | 4.72% | 3 |
|
|
2020
Q3 | $17.4M | Sell |
39,300
-1,135
| -3% | -$469K | 4.99% | 3 |
|
|
2020
Q2 | $14.7M | Sell |
40,435
-219
| -0.5% | -$73.4K | 4.63% | 3 |
|
|
2020
Q1 | $11.5M | Sell |
40,654
-426
| -1% | -$134K | 4.37% | 5 |
|
|
2019
Q4 | $13.3M | Sell |
41,080
-21
| -0.1% | -$6.37K | 3.86% | 4 |
|
|
2019
Q3 | $12M | Buy |
+41,101
| New | +$11.8M | 3.83% | 5 |
|
|
2019
Q1 | $11.4M | Sell |
41,553
-6,700
| -14% | -$1.67M | 3.69% | 5 |
|
|
2018
Q4 | $10.8M | Buy |
+48,253
| New | +$11.3M | 3.89% | 4 |
|
|
2018
Q2 | $10.1M | Sell |
48,648
-686
| -1% | -$146K | 3.09% | 7 |
|
|
2018
Q1 | $10.2M | Sell |
49,334
-400
| -0.8% | -$84K | 3.14% | 5 |
|
|
2017
Q4 | $9.44M | Sell |
49,734
-627
| -1% | -$120K | 2.88% | 7 |
|
|
2017
Q3 | $9.53M | Sell |
50,361
-600
| -1% | -$109K | 3.03% | 7 |
|
|
2017
Q2 | $8.89M | Sell |
50,961
-13,964
| -22% | -$2.35M | 2.94% | 7 |
|
|
2017
Q1 | $9.97M | Sell |
64,925
-4,060
| -6% | -$621K | 3.3% | 3 |
|
|
2016
Q4 | $9.73M | Sell |
68,985
-610
| -0.9% | -$89.9K | 3.33% | 4 |
|
|
2016
Q3 | $11.1M | Sell |
69,595
-14,725
| -17% | -$2.27M | 3.93% | 1 |
|
|
2016
Q2 | $12.5M | Sell |
84,320
-1,159
| -1% | -$171K | 4.36% | 2 |
|
|
2016
Q1 | $12.1M | Sell |
85,479
-984
| -1% | -$132K | 4.36% | 3 |
|
|
2015
Q4 | $12.3M | Buy |
+86,463
| New | +$11.5M | 4.27% | 3 |
|
|
2015
Q2 | $11.5M | Sell |
88,728
-3,340
| -4% | -$435K | 3.87% | 3 |
|
|
2015
Q1 | $12.4M | Hold |
92,068
| – | – | 4.21% | 2 |
|
|
2014
Q4 | $11.5M | Sell |
92,068
-4,990
| -5% | -$607K | 4.01% | 2 |
|
|
2014
Q3 | $11.8M | Sell |
97,058
-1,331
| -1% | -$162K | 4.27% | 1 |
|
|
2014
Q2 | $11.6M | Sell |
98,389
-2,195
| -2% | -$258K | 3.95% | 1 |
|
|
2014
Q1 | $12.1M | Sell |
100,584
-2,560
| -2% | -$304K | 4.26% | 1 |
|
|
2013
Q4 | $11.5M | Buy |
103,144
+1,335
| +1% | +$133K | 4.11% | 2 |
|
|
2013
Q3 | $9.38M | Sell |
101,809
-555
| -0.5% | -$50.2K | 3.64% | 3 |
|
|
2013
Q2 | $8.66M | Buy |
+102,364
| New | +$8.52M | 3.61% | 4 |
|
Other funds holding TMO
VCM
J.P. Marvel Investment Advisors's TMO Position: Q1 2026 in Review
J.P. Marvel Investment Advisors reduced its Thermo Fisher Scientific (TMO) stake by 0.22% in Q1 2026, selling an estimated $46.1K and leaving 38,035 shares worth $18.7M. The position accounts for 2.65% of the portfolio, ranked #11.
J.P. Marvel Investment Advisors first reported a position in TMO in Q2 2013 and has held it in 49 quarters since. The position peaked at $25.6M in Q4 2021. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- J.P. Marvel Investment Advisors held 38,035 shares of Thermo Fisher Scientific worth $18.7M as of Q1 2026.
- J.P. Marvel Investment Advisors sold 85 Thermo Fisher Scientific shares in Q1 2026, an estimated $46.1K.
- Thermo Fisher Scientific made up 2.65% of J.P. Marvel Investment Advisors's portfolio in Q1 2026, its #11 holding.
- J.P. Marvel Investment Advisors first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 49 quarters since.
- J.P. Marvel Investment Advisors's Thermo Fisher Scientific position peaked at $25.6M in Q4 2021.
- 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on J.P. Marvel Investment Advisors's 13F filing for Q1 2026, filed 6 May 2026.